These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25355653)

  • 21. Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia.
    Michalowsky B; Hoffmann W; Xie F
    J Alzheimers Dis; 2021; 83(1):77-87. PubMed ID: 34275901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing Measurement Properties of the English EQ-5D-Y 3-Level Version With the 5-Level Version in South Africa.
    Verstraete J; Amien R; Scott D
    Value Health Reg Issues; 2022 Jul; 30():140-147. PubMed ID: 35429927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.
    Greene ME; Rader KA; Garellick G; Malchau H; Freiberg AA; Rolfson O
    Clin Orthop Relat Res; 2015 Nov; 473(11):3383-90. PubMed ID: 25488404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia.
    Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F
    Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
    Pattanaphesaj J; Thavorncharoensap M
    Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.
    Zhu J; Yan XX; Liu CC; Wang H; Wang L; Cao SM; Liao XZ; Xi YF; Ji Y; Lei L; Xiao HF; Guan HJ; Wei WQ; Dai M; Chen W; Shi JF
    Qual Life Res; 2021 Mar; 30(3):841-854. PubMed ID: 32930993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
    Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
    Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Psychometric Properties of the EQ-5D-3L-Y and EQ-5D-5L-Y Instruments in Spanish Children and Adolescents.
    Pérez-Sousa MÁ; Olivares PR; Ramírez-Vélez R; Gusi N
    Value Health; 2021 Dec; 24(12):1799-1806. PubMed ID: 34838278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults.
    Ferreira LN; Ferreira PL; Ribeiro FP; Pereira LN
    Health Qual Life Outcomes; 2016 Jun; 14():89. PubMed ID: 27267761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B.
    Jia YX; Cui FQ; Li L; Zhang DL; Zhang GM; Wang FZ; Gong XH; Zheng H; Wu ZH; Miao N; Sun XJ; Zhang L; Lv JJ; Yang F
    Qual Life Res; 2014 Oct; 23(8):2355-63. PubMed ID: 24627090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of the EQ-5D-5L questionnaire among the general population of Poland.
    Młyńczak K; Golicki D
    Qual Life Res; 2021 Mar; 30(3):817-829. PubMed ID: 33099710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.
    Pickard AS; De Leon MC; Kohlmann T; Cella D; Rosenbloom S
    Med Care; 2007 Mar; 45(3):259-63. PubMed ID: 17304084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients.
    Yu H; Zeng X; Sui M; Liu R; Tan RL; Yang J; Huang W; Luo N
    Qual Life Res; 2021 Mar; 30(3):855-866. PubMed ID: 32965633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population.
    Agborsangaya CB; Lahtinen M; Cooke T; Johnson JA
    Health Qual Life Outcomes; 2014 May; 12():74. PubMed ID: 24885017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.
    Garratt AM; Furunes H; Hellum C; Solberg T; Brox JI; Storheim K; Johnsen LG
    Health Qual Life Outcomes; 2021 May; 19(1):155. PubMed ID: 34049574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing the properties of the EQ-5D-5L and EQ-5D-3L in general population in Iran.
    Rezaei S; Woldemichael A; Ahmadi S; Mohamadi Bolbanabad A; Zahir Abdullah F; Piroozi B
    Int J Health Plann Manage; 2021 Sep; 36(5):1613-1625. PubMed ID: 34013594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.
    Bató A; Brodszky V; Gergely LH; Gáspár K; Wikonkál N; Kinyó Á; Szabó Á; Beretzky Z; Szegedi A; Remenyik É; Kiss N; Sárdy M; Rencz F
    Qual Life Res; 2021 May; 30(5):1477-1490. PubMed ID: 33534032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.
    Pan CW; Sun HP; Wang X; Ma Q; Xu Y; Luo N; Wang P
    Qual Life Res; 2015 Jul; 24(7):1767-74. PubMed ID: 25540029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
    Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
    Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.